ISSCA has announced plans to launch the first bilingual (English and Spanish) regenerative medicine newsletter.
MIAMI, Jan. 15, 2018—The International Society for Stem Cell Application (ISSCA) will launch the first bilingual (English and Spanish) regenerative medicine newsletter January 23, 2018. The monthly newsletter will be available for free to email subscribers and shared through ISSCA social media channels.
The newsletter will include three sections:
- Regenerative Medicine Business News
- Regenerative Medicine Research and clinical applications
- Upcoming Regenerative Medicine Training
Regenerative Medicine Business News will provide the latest updates on policies, legislative, regulatory and reimbursement initiatives to support research and development of regenerative medicine products, and business development and investor information on opportunities in the fast-growing stem cell and regenerative medicine market.
Regenerative Medicine Research and clinical applications will follow the latest findings on regenerative medicine research and development—from tissue engineering to cell therapies, and the different challenges involved in live tissue handling and manufacturing. In addition, the newsletter will include information on the latest clinical applications of regenerative medicine therapies.
The newsletter will also include schedules and registration information on upcoming regenerative medicine training and certification courses, along with registration information.
To subscribe to ISSCA’s newsletter, send an email request with your contact information to email@example.com.
To learn more, visit the ISSCA website, email firstname.lastname@example.org, or call 305-560-5337.
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.